With the FTC's conditional approval, Medtronic completes its $1.1B acquisition of Intersect ENT
To get approval for the deal, Medtronic agreed to sell an Intersect subsidiary to soothe the FTC's concerns.
Stay updated with breaking news from Intersect Ent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
To get approval for the deal, Medtronic agreed to sell an Intersect subsidiary to soothe the FTC's concerns.
Intersect ENT, Inc. (NASDAQ:XENT – Get Rating) was the recipient of a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 2,870,000 shares, a growth of 41.4% from the March 31st total of 2,030,000 shares. Currently, 8.7% of the shares of the company are short […]
Calamos Advisors LLC purchased a new position in Intersect ENT, Inc. (NASDAQ:XENT – Get Rating) in the fourth quarter, HoldingsChannel.com reports. The fund purchased 202,386 shares of the medical equipment provider’s stock, valued at approximately $5,527,000. Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Two […]
StockNews.com assumed coverage on shares of Intersect ENT (NASDAQ:XENT – Get Rating) in a report issued on Thursday. The brokerage issued a hold rating on the medical equipment provider’s stock. Shares of Intersect ENT stock opened at $27.75 on Thursday. The stock has a 50 day moving average of $27.46 and a 200 day moving […]
Intersect ENT, Inc. (NASDAQ:XENT – Get Rating) has been given a consensus recommendation of “Hold” by the six brokerages that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating and five have assigned a hold rating to the company. The average 12-month price objective among brokers […]